Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581542 · ClinicalTrials.gov registry record · Phase 4
Moxifloxacin vs. Polytrim for Conjunctivitis
A Phase 4 study of Conjunctivitis, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 4
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT00581542: Completed Phase 4 study of Conjunctivitis, sponsored by University of Rochester.
NCT00581542 is a Phase 4 study of Conjunctivitis that has completed, run by University of Rochester. The registered enrollment target is 124 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581542, a Phase 4 study of Conjunctivitis, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.
Conditions Studied
Interventions
- DRUG moxifloxacin
- DRUG polytrim
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2007-03 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
What the finished NCT00581542 record still lists
NCT00581542 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Conjunctivitis appearing as the primary indexed condition, and to 2 interventions - of which moxifloxacin is the first listed.
NCT00581542 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00581542 about?
NCT00581542 is a clinical study titled "Moxifloxacin vs. Polytrim for Conjunctivitis". The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of t...
What is the current status of trial NCT00581542?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 124 participants. The study started on 2007-03. Estimated completion is 2012-03.
What conditions does trial NCT00581542 study?
This clinical trial studies the following conditions: Conjunctivitis.
What interventions are being tested in trial NCT00581542?
The interventions under investigation include: moxifloxacin (DRUG), polytrim (DRUG).
Who is sponsoring clinical trial NCT00581542?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00581542 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Conjunctivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00581542's enrollment target sits among peer trials
124 656th of 2000 higher than 1,340 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia